OMER Omeros Corp
- Stocks
- Healthcare
- NASDAQ: OMER
Price (delayed)
$6.99
Market cap
$475.71M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.12
Enterprise value
$855.82M
Relative Growth:
Rel. Growth:
12
Relative Strength:
Rel. Strength:
83
Relative Valuation:
Rel. Valuation:
N/A
Relative Profitability:
Rel. Profitability:
8
Omeros is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous
Highlights
The net income has grown by 20% from the previous quarter and by 13% YoY
The EPS is up by 20% since the previous quarter and by 10% year-on-year
Omeros's quick ratio has plunged by 85% YoY and by 42% from the previous quarter
OMER's equity has dropped by 84% year-on-year and by 7% since the previous quarter
Key stats
What are the main financial stats of OMER
Market
Valuations
Earnings
Shares outstanding
68.06M
Market cap
$475.71M
Enterprise value
$855.82M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
PEG
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$138.39M
Net income
-$122.47M
EBIT
-$111.58M
EBITDA
-$110.55M
Free cash flow
-$118.9M
Per share
Balance sheet
Liquidity
EPS
-$2.12
EPS diluted
-$2.12
Free cash flow per share
-$2.03
Book value per share
-$3.9
Revenue per share
$0
TBVPS
$3.42
Total assets
$200.57M
Total liabilities
$429.25M
Debt
$382.01M
Equity
-$228.69M
Working capital
-$15.86M
Debt to equity
-1.67
Current ratio
0.81
Quick ratio
0.41
Net debt/EBITDA
-3.44
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-47.7%
Return on equity
N/A
Return on invested capital
-18.9%
Return on capital employed
-97%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OMER stock price
How has the Omeros stock price performed over time
Intraday
3.86%
1 week
-8.98%
1 month
52.62%
1 year
58.86%
YTD
-29.25%
QTD
70.49%
Financial performance
How have Omeros's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$138.39M
Net income
-$122.47M
Gross margin
N/A
Net margin
N/A
Omeros's operating income has increased by 26% YoY and by 16% from the previous quarter
The net income has grown by 20% from the previous quarter and by 13% YoY
Price vs fundamentals
How does OMER's price correlate with its fundamentals
Growth
What is Omeros's growth rate over time
Valuation
What is Omeros stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 20% since the previous quarter and by 10% year-on-year
OMER's equity has dropped by 84% year-on-year and by 7% since the previous quarter
Efficiency
How efficient is Omeros business performance
The ROA has contracted by 42% YoY but it has grown by 8% from the previous quarter
Omeros's ROIC has decreased by 34% YoY but it has increased by 7% from the previous quarter
Dividends
What is OMER's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OMER.
Financial health
How did Omeros financials performed over time
The total assets is 53% less than the total liabilities
Omeros's quick ratio has plunged by 85% YoY and by 42% from the previous quarter
The current ratio has plunged by 76% YoY and by 30% from the previous quarter
OMER's equity has dropped by 84% year-on-year and by 7% since the previous quarter
Omeros's debt to equity has soared by 53% YoY and by 14% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.